Aurora, IL15 Active Studies

Type 2 Diabetes Clinical Trials in Aurora, IL

Find 15 actively recruiting type 2 diabetes clinical trials in Aurora, IL. Connect with local research sites and explore new treatment options.

15
Active Trials
13
Sponsors
7,833
Enrolling

Recruiting Type 2 Diabetes Studies in Aurora

NCT06525259Recruiting

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic ...

Aurora, IL3,600 participantsGeorge Washington University
View Study Details
NCT05544266Recruiting

Rare and Atypical Diabetes Network

RADIANT is a network of 14 clinical sites and several laboratories dedicated to the study of atypical diabetes. The objective of this study is to define new forms of diabetes and the unique mechanism...

Aurora, IL2,000 participantsUniversity of South Florida
View Study Details
NCT06959316Recruiting

T1D Pregnancy & Me

T1D Pregnancy \& Me will partner with pregnant participants living with type 1 diabetes (T1D) in the United States to collect real-world data on management of T1D in pregnancy. This is a remote study ...

Aurora, IL500 participantsJaeb Center for Health Research
View Study Details
NCT07228117Recruiting

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

The purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync in people with diabet...

Aurora, IL400 participantsMedtronic MiniMed, Inc.
View Study Details
NCT07222332Recruiting

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes. Participation in the study will last about 60 weeks....

Aurora, IL300 participantsEli Lilly and Company
View Study Details
NCT07579702Recruiting

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

This multi-center, randomized, cross-over trial will evaluate the efficacy of the Omnipod 6 System compared with the Omnipod 5 System in individuals with type 1 or type 2 diabetes and suboptimal glyce...

Aurora, IL200 participantsInsulet Corporation
View Study Details
NCT05766735Recruiting

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

A Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + Glycemic Excursion Minimization (RC+GEM); a program that prov...

Aurora, IL200 participantsChiara Fabris, PhD
View Study Details
NCT04791371Recruiting

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal...

Aurora, IL150 participantsUniversity of Colorado, Denver
View Study Details
NCT02734277Recruiting

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodula...

Aurora, IL111 participantsNational Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
NCT05008276Recruiting

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or s...

Aurora, IL100 participantsPetter Bjornstad
View Study Details
NCT07224321Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 year...

Aurora, IL100 participantsMannkind Corporation
View Study Details
NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Aurora, IL66 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
View Study Details
NCT05822609Recruiting

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and s...

Aurora, IL60 participantsUniversity of Washington
View Study Details
NCT07005362Recruiting

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

The goal of this observational study is to evaluate the feasibility and acceptability of a 12-week intervention utilizing a Fitbit and artificial intelligence (AI)-delivered diabetes self-management e...

Aurora, IL36 participantsUniversity of Colorado, Denver
View Study Details
NCT03899883Recruiting

Uric Acid Lowering Trial in Youth Onset T2D

Adolescents and young adults with youth-onset type 2 diabetes (T2D) are disproportionally impacted by hyperuricemia compared to non-diabetic peers and youth with type 1 diabetes (T1D). In fact, 50% of...

Aurora, IL10 participantsUniversity of Colorado, Denver
View Study Details

About Type 2 Diabetes Clinical Trials in Aurora

Type 2 diabetes is a chronic metabolic condition affecting over 37 million Americans, characterized by insulin resistance and progressive loss of beta-cell function. While metformin remains the first-line treatment, the treatment landscape has expanded dramatically with GLP-1 receptor agonists (semaglutide, tirzepatide), SGLT2 inhibitors (empagliflozin, dapagliflozin), and dual GIP/GLP-1 agonists showing both glycemic and cardiovascular benefits. Clinical trials are now exploring triple-hormone agonists, oral GLP-1 formulations, islet cell regeneration therapies, and precision medicine approaches that tailor treatment to individual metabolic profiles. Patients with uncontrolled HbA1c on current medications, those with diabetic complications, or newly diagnosed patients may qualify for enrollment.

There are currently 15 type 2 diabetes clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 7,833 participants. Research is being sponsored by George Washington University, University of South Florida, Jaeb Center for Health Research and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 2 Diabetes Clinical Trials in Aurora — FAQ

Are there type 2 diabetes clinical trials in Aurora?

Yes, there are 15 type 2 diabetes clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What type 2 diabetes treatments are being tested?

The 15 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for type 2 diabetes.

Data updated July 13, 2026 from ClinicalTrials.gov